Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia

BACKGROUND: Dihydroartemisinin–piperaquine has been Indonesia’s first-line anti-malarial treatment since 2008. Annual therapeutic efficacy studies (TES) done in the last 12 years showed continued high treatment efficacy in uncomplicated Plasmodium falciparum malaria. Although these studies did not s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmasari, Farindira Vesti, Asih, Puji Budi Setia, Rozi, Ismail Ekoprayitno, Wangsamuda, Suradi, Risandi, Rifqi, Dewayanti, Farahana Kresno, Permana, Dendi Hadi, Syahrani, Lepa, Prameswari, Helen Dewi, Basri, Herdiana H., Bustos, Maria Dorina G., Charunwatthana, Prakaykaew, Dondorp, Arjen M., Imwong, Mallika, Syafruddin, Din
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410932/
https://www.ncbi.nlm.nih.gov/pubmed/37553646
http://dx.doi.org/10.1186/s12936-023-04658-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410932/
https://www.ncbi.nlm.nih.gov/pubmed/37553646
http://dx.doi.org/10.1186/s12936-023-04658-4

Ejemplares similares